PURPOSE: To determine age-dependent cutoff values for secondary exhaustion criteria for a general population free of exercise limiting chronic conditions; to describe the percentage of participants reaching commonly used exhaustion criteria during a cardiopulmonary exercise test (CPET); and to analyze their oxygen uptake at the respective criteria to quantify the impact of a given criterion on the respective oxygen uptake (V˙O2) values. METHODS: Data from the COmPLETE-Health Study were analyzed involving participants from 20 to 91 yr of age. All underwent a CPET to maximal voluntary exertion using a cycle ergometer. To determine new exhaustion criteria, based on maximal respiratory exchange ratio (RERmax) and age-predicted maximal HR (APMHR), one-sided lower tolerance intervals for the tests confirming V˙O2 plateau status were calculated using a confidence level of 95% and a coverage of 90%. RESULTS: A total of 274 men and 252 women participated in the study. Participants were nearly equally distributed across age decades from 20 to >80 yr. A V˙O2 plateau was present in 32%. There were only minor differences in secondary exhaustion criteria between participants exhibiting a V˙O2 plateau and participants not showing a V˙O2 plateau. New exhaustion criteria according to the tolerance intervals for the age group of 20 to 39 yr were: RERmax ≥ 1.13, APMHR210 - age ≥ 96%, and APMHR208 × 0.7 age ≥ 93%; for the age group of 40 to 59 yr: RERmax ≥ 1.10, APMHR210 - age ≥ 99%, and APMHR208 × 0.7 age ≥ 92%; and, for the age group of 60 to 69 yr: RERmax ≥ 1.06, APMHR210 - age ≥ 99%, and APMHR208 × 0.7 age ≥ 89%. CONCLUSIONS: The proposed cutoff values for secondary criteria reduce the risk of underestimating V˙O2max. Lower values would increase false-positive results, assuming participants are exhausted although, in fact, they are not.
PURPOSE: To determine age-dependent cutoff values for secondary exhaustion criteria for a general population free of exercise limiting chronic conditions; to describe the percentage of participants reaching commonly used exhaustion criteria during a cardiopulmonary exercise test (CPET); and to analyze their oxygen uptake at the respective criteria to quantify the impact of a given criterion on the respective oxygen uptake (V˙O2) values. METHODS: Data from the COmPLETE-Health Study were analyzed involving participants from 20 to 91 yr of age. All underwent a CPET to maximal voluntary exertion using a cycle ergometer. To determine new exhaustion criteria, based on maximal respiratory exchange ratio (RERmax) and age-predicted maximal HR (APMHR), one-sided lower tolerance intervals for the tests confirming V˙O2 plateau status were calculated using a confidence level of 95% and a coverage of 90%. RESULTS: A total of 274 men and 252 women participated in the study. Participants were nearly equally distributed across age decades from 20 to >80 yr. A V˙O2 plateau was present in 32%. There were only minor differences in secondary exhaustion criteria between participants exhibiting a V˙O2 plateau and participants not showing a V˙O2 plateau. New exhaustion criteria according to the tolerance intervals for the age group of 20 to 39 yr were: RERmax ≥ 1.13, APMHR210 - age ≥ 96%, and APMHR208 × 0.7 age ≥ 93%; for the age group of 40 to 59 yr: RERmax ≥ 1.10, APMHR210 - age ≥ 99%, and APMHR208 × 0.7 age ≥ 92%; and, for the age group of 60 to 69 yr: RERmax ≥ 1.06, APMHR210 - age ≥ 99%, and APMHR208 × 0.7 age ≥ 89%. CONCLUSIONS: The proposed cutoff values for secondary criteria reduce the risk of underestimating V˙O2max. Lower values would increase false-positive results, assuming participants are exhausted although, in fact, they are not.
Authors: Renske Meijer; Martijn van Hooff; Nicole E Papen-Botterhuis; Charlotte J L Molenaar; Marta Regis; Thomas Timmers; Lonneke V van de Poll-Franse; Hans H C M Savelberg; Goof Schep Journal: Int J Gen Med Date: 2022-04-05
Authors: Matthew Nayor; Ravi V Shah; Melissa Tanguay; Jasmine B Blodgett; Ariel Chernofsky; Patricia E Miller; Vanessa Xanthakis; Rajeev Malhotra; Nicholas E Houstis; Raghava S Velagaleti; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis Journal: Am J Cardiol Date: 2021-08-12 Impact factor: 3.133
Authors: Karsten Königstein; Jonathan Wagner; Denis Infanger; Raphael Knaier; Gilles Nève; Christopher Klenk; Justin Carrard; Timo Hinrichs; Arno Schmidt-Trucksäss Journal: Front Cardiovasc Med Date: 2022-04-28
Authors: Jonathan Wagner; Max Niemeyer; Denis Infanger; Timo Hinrichs; Clement Guerra; Christopher Klenk; Karsten Königstein; Christian Cajochen; Arno Schmidt-Trucksäss; Raphael Knaier Journal: PLoS One Date: 2021-01-11 Impact factor: 3.240
Authors: Jonathan Wagner; Max Niemeyer; Denis Infanger; Otmar Pfister; Jonathan Myers; Arno Schmidt-Trucksäss; Raphael Knaier Journal: Front Physiol Date: 2021-11-25 Impact factor: 4.566
Authors: Ian R Villanueva; John C Campbell; Serena M Medina; Theresa M Jorgensen; Shannon L Wilson; Siddhartha S Angadi; Glenn A Gaesser; Jared M Dickinson Journal: Physiol Rep Date: 2021-09